IL6 and COVID-19: Therefore, close monitoring of changes in IL-6 and ferritin concentrations in COVID-19 patients, especially those at high risk for VTE, is of great value in determining changes in the disease and in reducing the rates of severe illness, VTE morbidity and mortality.